COMP <GO>
PYPD vs KRMD // REVENUE GROWTH (YOY)
PolyPid Ltd. (NASDAQ) VS. KORU Medical Systems Inc. (NASDAQ) • 15-METRIC TALLY: PYPD 1
— KRMD 4
■ METRIC PARITY
LAST: $5.59 (-3.29%) • MKT CAP: $113.5M
revenue-growth
—
LAST: $3.23 (+0.31%) • MKT CAP: $149.1M
revenue-growth
22.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PYPD VS. KRMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PYPD | KRMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 62.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -28.70% | -6.30 | KRMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -24.74% | 0.31% | -25.05 | KRMD | /fcf-yield <GO> |
| Operating Margin | — | -7.20% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -6.40% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | — | 22.20% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 8.05 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | KRMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 55.8 | +3.50 | PYPD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $113.5M | $149.1M | -$35.6M | KRMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PYPD REV | KRMD REV | PYPD GROSS % | KRMD GROSS % | PYPD FCF | KRMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $41.1M | — | 62.3% | -$28.1M | $462.4K |
| FY 2024 | $0 | $33.6M | — | 63.4% | -$22.0M | -$319.7K |
| FY 2023 | $0 | $28.5M | — | — | -$17.2M | -$4.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PYPD // BETA —
KRMD // BETA —